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Abstract: Background and objectives: It has been suggested that the COVID-19 pandemic impaired
people’s moods and general levels of physical activity, but the way in which each country is coping
with the situation may result in different outcomes. The aim of the present study was to compare
the mental health and physical activity levels between residents of Brazil and Switzerland during
the social distancing period associated with COVID-19 pandemic. Materials and Methods: A self-
administered questionnaire aiming to assess personal, quarantine, physical activity, and mood state
disorders data was answered by 114 participants (57 from each country) of both sexes. Results:
Swiss participants presented a higher frequency of people (47.4%) not abiding by social distancing
measures compared to Brazilian participants (1.8%; p < 0.001, effect size = 0.56). There were no
significant differences between the participants from the two countries regarding physical activity
levels (p = 0.09). The Swiss presented a higher frequency (78.9%) of people without symptoms of
depression compared to Brazilians (31.6%; p < 0.001, effect size = 0.48). The Swiss also presented
a higher frequency (77.2%) of people without symptoms of anxiety compared to Brazilians (35.1%;
p < 0.001, effect size = 0.43). There was a significant association between the restriction level and
depression symptoms (p = 0.01, effect size = 0.25) but not with anxiety symptoms (p = 0.21, effect
size = 0.16). Conclusions: According to the preliminary results, Brazilians presented a much higher
frequency of depression and anxiety symptoms, which can be explained by characteristics other than
the restriction level.
Keywords: pandemic; social distancing; COVID-19; physical exercise; mood state; depression;
anxiety
1. Introduction
The emergence and rapid increase in coronavirus case numbers (COVID-19), which is
caused by a novel coronavirus, SARS-CoV-2, posed complex challenges for global public
health, research, and medical communities [1]. After the initial outbreak, which occurred
in December 2019 in Wuhan, China [2], the virus rapidly spread across China, and reached
Europe and both Americas [3,4]. On 11 March 2020, the World Health Organization (WHO)
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declared the COVID-19 outbreak to be a pandemic [2], and the number of new cases and
deaths are currently increasing around the world.
Human coronaviruses typically cause respiratory and enteric infections [5], and the
main common reported symptoms include fever, cough, fatigue, slight dyspnea, sore throat,
headache, gastrointestinal issues, and neurologic symptoms, including altered mental
status, ageusia, and anosmia [6–9]. In this context, there are already studies showing
psychiatric symptoms in people infected by COVID-19 [10,11]. It is notable that mental
health disorders, such as depression or anxiety (ranging from 6 to 48.3%), have already
been found in patients unaffected by COVID-19 [10,12–15].
The increasing menace of the COVID-19 pandemic, measurements of social distancing
to avoid the spread of the virus, disrupted travel plans, and media information overload are
some of the possible factors associated with this scenario [16]. Dissatisfaction with health
information, a high risk of contracting COVID-19, high deaths number, low educational lev-
els, and economic worries are other cited factors associated with poor mental health [12–14].
Additionally, both physical activity and physical fitness levels have an important role in
managing mental health status [17–19]. In this direction, despite the concern about the
mental health being a common problem to the whole world, it is possible that the severity
of the problem differs between countries that have a different economic situation and that
are facing the pandemic differently and, for this reason, are showing different results in
terms of the number of cases and deaths [20]. In this vein, the comparison of mental health
status during the COVID-19 pandemic between countries can bring illuminating results on
how the COVID-19 pandemic is able to compromise the health of unaffected people.
In this sense, Switzerland and Brazil are two countries that are facing the pandemic
quite differently, and consequently with a substantial differences in the number of cases
and deaths. The number of confirmed cases in Brazil, up to September 2020, was more than
three times higher (22,196 per million) than the number of cases in Switzerland (6193 per
million) [2]. The number of COVID-19 deaths is also three times higher in Brazil (676 deaths
per million) than in Switzerland (242 deaths per million) [2]. The average economic status
is also worse in Brazil, where the income per capita is $14,750, compared to the income per
capita in Switzerland which is $56,580 [2]. Together, these particularities of each country
can result in differences in both physical activity levels and mental health during the
COVID-19 pandemic.
Therefore, the aim of the present study was to compare mental health (i.e., depression
and anxiety symptoms) and physical activity levels during the COVID-19 pandemic in
a convenience sample from two countries (Brazil and Switzerland) that dealt with the
pandemic in a different manner. Secondarily, we aimed to compare the restriction level
adopted and the family income between participants from these two countries. The hy-
pothesis of the present study was that there is a significant association between the country
and the presence of anxiety and depression symptoms.
2. Materials and Methods
2.1. Ethics Approval
All participants voluntarily gave their informed consent to participate in the study
after having read the purpose of the study in the first section of the electronic survey.
The study was approved in 12 June, 2020 by the Human Research Ethics Committee of the
Federal University of São Paulo UNIFESP (Approval number: 4.073.442) and conformed to
the principles outlined in the Declaration of Helsinki.
2.2. Participants
Residents from Brazil and Switzerland were invited to participate through websites,
e-mail, and social networks (Instagram, Facebook, and WhatsApp) of the involved re-
searchers and institutions. The inclusion criteria included the following, participants had
to be: (i) over 18 years old, and (iv) from urban regions in both countries. Participants who
did not complete the questionnaire or answered it inappropriately were excluded from the
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survey. A convenience sample comprised of 114 participants (57 from Brazil and 57 from
Switzerland) of both sexes (65 male and 49 female), from 28 to 85 years old, took part in
this study.
2.3. Experimental Design
This was a cross-sectional study based on self-administered questionnaires applied
from 2 to 12 June, 2020. Both countries were at different stages of national outbreaks
according to the pandemic’s progression. The recommendations for social distancing
from the corresponding ministries of health in Brazil and Switzerland, at the time of
data collection, were different as follows: The Brazilian government was implementing
nationwide shutdowns of schools, universities, bars, restaurants, and commerce, while the
Swiss government was reopening the country respecting physical distancing policies.
The questionnaires were structured and shared using the digital platform Google
Forms and contained four sections. There was a Brazilian Portuguese version and a German
version of the questionnaire. The first section dealt with general data about the participant
and raised issues related to sex (male or female), age (open-ended question), body mass
(open-ended question), height (open-ended question), country and region where he or
she lives (open-ended question), and total family income measured in multiples of the
minimum wage (less than 1 minimum wage, minimum wage between 1–2, minimum wage
between 3–6, minimum wage between 7–10, more than 11 minimum wages). A minimum
wage corresponds to less than 200 dollars US per month.
The second section contained questions related to the current level of restriction on
daily activities during the quarantine (taking complete measures of social distancing and
did not go out to perform any activity, leaving only for essential non-work activities,
leaving only for essential activities including work activities, and not taking any measures
of social distancing), the number of days participants adopted social distancing measures
in their own daily lives independently from their government’s instructions (less than
30 days, between 30–60 days, more than 60 days).
The third section was dedicated to physical activity level. The International Physical
Activity Questionnaire (IPAQ) proposed by the WHO in 1998 was used. This instrument
has acceptable measurement properties to estimate physical activity levels with interna-
tional validation results previously reported and validated for Brazilian Portuguese and
German [2,21]. According to the answers provided by the subject, the level of physical
activity was classified initially into five categories, according to Matsudo et al. [22]: very
active (those who perform vigorous activities 5 days per week and ≥30 min per session
or vigorous activities ≥3 days per week and ≥20 min per session and moderate activities
≥5 days per week and ≥30 min per session), active (those who perform vigorous activities
≥3 days per week and ≥20 min per session; or moderate activities ≥5 days per week and
≥30 min per session; or any combined activity: ≥5 days per week and ≥150 min per week
such as walking and moderate and vigorous), irregularly active A (those who perform
physical activities but it is insufficient to be classified as active because it does not comply
with the recommendations regarding frequency or duration), irregularly active B (those
who perform physical activity but it is insufficient to be classified as irregularly active A be-
cause it does not comply with either the frequency or duration recommendations), and not
active (those who do not perform any physical activity for at least 10 continuous minutes
during the week). For data analysis purposes, irregularly active A and irregularly active B
categories were grouped into a single irregularly active category. For analysis purposes,
scores from 0 to 3 were assigned to activity levels, where 0 referred to the lowest level of
activity (not active) and 3 to the highest level of activity (very active). After that, the IPAQ
questionnaire was also used to assess the exercise routine in the period prior to quarantine
and the recommended social distancing measures (prior to March, 2020). To analyze the
effect of social distancing on the level of physical activity, a comparison between the two
periods was performed. For analysis purposes, scores from −1 to 1 were assigned to the
change in the level of physical activity between current and previous pandemic period,
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where −1 referred to a reduction in the physical activity level, 0 referred to no difference in
physical activity level, and 1 referred to an increase in physical activity level.
The fourth section aimed to screen mental health. We used Patient Health Questionnaire-
9 (PHQ-9) and General Anxiety Disorder-7 (GAD-7) to assess the current symptoms of
depression and anxiety, respectively. PHQ-9 is an instrument widely used to identify indi-
viduals at risk of depression and, in the current study, the validated PHQ-9 for Brazilian
Portuguese and German [22,23] was used. The PHQ-9 provides a final score ranging from
0 to 27. Scores less than 4 suggest a minimal depression, scores 5 to 9 suggest a mild depres-
sion, scores 10 to 14 suggest a moderate depression, scores 15 to 19 suggest a moderately
severe depression, and scores 20 or greater suggest a severe depression. For analysis pur-
poses, scores from 0 to 2 were assigned to the levels of depression, where 0 referred to the
minimal depression, score 1 to mild depression and score 3 referred to moderate, moderate
severe or severe depression. GAD-7 aims to identify possible generalized anxiety disor-
ders and also has a validated Portuguese and German version [24–26]. The questionnaire
provides a final score ranging from 0 to 21. Scores less than 4 suggest no anxiety disorder,
scores 5 to 9 suggest a mild anxiety, scores 10 to 14 suggest a moderate anxiety, and scores
15 or greater suggest a severe anxiety disorder. For analysis purposes, scores from 0 to
2 were assigned to the anxiety symptoms, where 0 referred to the no anxiety disorder, score
1 to a mild anxiety and score 2 referred to moderate or severe anxiety disorder.
2.4. Statistical Analysis
According to the Kolmogorov–Smirnov test, only the variables age, weight, and height
presented a normal distribution. The Student’s T-test was used to verify differences between
the two countries according to age, body mass, and height. The measures of the effect size
were calculated by dividing the mean difference by the standard deviation. The magnitude
of the effect sizes was judged according to the following criteria: d = 0.2 was considered
a ‘small’ effect size; 0.5 represented a ‘medium’ effect size; and 0.8 indicated a ‘large’
effect size [27]. To compare between the countries, a chi-square test was employed using
the PHQ-9 score, GAD-7 score, IPAQ actual level, change in IPAQ level, educational
level, restriction level, and social distancing duration. Data were grouped so that all
expected frequencies were higher than five. Cramer’s V was used as a measure of effect
size for chi-square tests [28]. When data could not be grouped and there were expected
frequencies lower than five, a Fisher test was employed. Statistical analysis was performed
using SPSS v 21.0 (Chicago, IL, USA). In all comparisons, p values < 5% were considered
statistically significant.
3. Preliminary Results
Participants from Brazil and from Switzerland presented no difference according to
age, body mass, and body height (Table 1).
Table 1. Descriptive characteristics of participants.
Variables Brazil Switzerland p-Value Cohen’s d Value
Age (years) 53.47 ± 9.74 56.72 ± 14.36 0.11 0.26
Body mass (kg) 80.04 ± 14.92 77.20 ± 13.26 0.37 0.20
Body height (cm) 171.63 ± 9.36 173.44 ± 9.31 0.27 0.19
Values were expressed as mean ± SD.
According to the analysis on participants’ family income, in Switzerland, 100% of the
respondents received the equivalent of more than $2000 per month, while in Brazil, only
38.5% of the respondents received an equivalent amount. In Brazil, 3.5% of the participants
received up to $200, 5.5% received up to $400, 24.5% received up to $1200, and 28.0%
received up to $2000. There was a higher frequency of Swiss residents than of Brazilian
residents who received the equivalent of more than $2000 per month.
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The frequency of male participants was 54% for Brazil and 60% for Switzerland.
There was no significant difference between countries in relation to the male and female
participation in the present study (Table 2).
Table 2. Chi-square test of association between country and analyzed variables.
Variables X2 Df p-Value Cramer’s V
Sex 0.32 1 0.57 0.05
Social distancing duration 1.56 2 0.46 0.12
Restriction level 35.46 3 <0.001 * 0.56
Family income 54.78 4 <0.001 * 0.69
IPAQ level 6.42 3 0.09 0.24
Change in IPAQ level 4.46 2 0.11 0.11
PHQ9 25.87 2 <0.001 * 0.48
GAD7 21.07 2 <0.001 * 0.43
* Statistically significant association (p ≤ 0.05); International physical activity questionnaire—IPAQ; Patient Health
Questionnaire-9—PHQ-9; General Anxiety Disorder-7—GAD-7; difference between the current and pre-pandemic
categories of IPAQ—∆ IPAQ; qui-square result—X2; degrees of freedom—df.
Of all the participants, seven percent (8.8% of the Brazilians and 5.3% of the Swiss)
had adopted social isolation measures in their daily lives for less than 30 days, 25.4% (21.1%
of the Brazilians and 29.8% of the Swiss) between 30 and 60 days, and 66.7% (70.2% of the
Brazilians and 63.2% of the Swiss) for more than 60 days.
There was no association between the country and the social distancing duration that
each participant had implemented in their daily life (Table 2). Of total participants, 8.8%
(14.0% of the Brazilians and 3.5% of the Swiss) were taking complete measures of social
distancing and did not go out to perform any activity, 41.2% (57.9% of the Brazilians and
24.6% of the Swiss) maintained partial restrictions, leaving only for essential non-work
activities, 25.4% (26.3% of the Brazilians and 24.6% of the Swiss) maintained partial restric-
tions, leaving only for essential activities including work activities, and 24.6% (1.8% of the
Brazilians and 47.4% of the Swiss) were not taking any measures of social distancing. There
was a significant association between the country and the level of restriction (p < 0.001,
and effect size = 0.56). There was a higher frequency of Swiss residents who were not
taking any measures of social distancing (Table 2).
During the social distancing period, 8.8% (12.3% of the Brazilians and 5.3% of the
Swiss) were not active, 10.5% (15.8% of the Brazilians and 5.3% of the Swiss) were irregularly
active, 39.5% (31.6% of the Brazilians and 47.4% of the Swiss) were active, and 41.2% (40.4%
of the Brazilians and 42.1% of the Swiss) were very active. There was no association
between the country and the current physical activity level (Table 2).
Regarding the change in the physical activity level currently adopted compared to
what was adopted before the pandemic period, 23.7% (31.6 of the Brazilians and 15.8% of
the Swiss) reduced the physical activity level, 68.4% (63.2% of the Brazilians and 73.7%
of the Swiss) maintained the physical activity level, and 7.9% (5.3% of the Brazilians and
10.5% of the Swiss) increased the physical activity level. There was no association between
the country and the change in physical activity level (Table 2).
Concerning the symptoms of depression, 55.3% (31.6% of the Brazilians and 78.9% of
the Swiss) had symptoms classified as minimal depression, 29.8% (45.6% of the Brazilians
and 14% of the Swiss) a mild depression, and 14.9% (22.8% of the Brazilians and 7% of
the Swiss) a moderate or severe depression. Finally, 56.1% (35.1% of the Brazilians and
77.2% of the Swiss) had no anxiety disorder, 33.3% (47.4% of the Brazilians and 19.3% of
the Swiss) had mild anxiety, 10.5% (17.5% of the Brazilians and 3.5% of the Swiss) had
moderate or severe anxiety. There was a significant association between the country and
depression (p < 0.001, and effect size = 0.48) or anxiety symptoms (p < 0.001, and effect
size = 0.43). Switzerland presented a higher frequency of people without symptoms of
depression and anxiety than Brazil (Table 2).
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The association between the restriction level and the depression or anxiety status were
also studied. The results showed a significant association between the restriction level
and depression symptoms (p = 0.01, and effect size = 0.25) but not with anxiety symptoms
(p = 0.21, and effect size = 0.16) (Table 3).
Table 3. Chi-square test of association between restriction level, PHQ-9, and GAD-7.
Variables X2 Df p Value Cramer’s V
PHQ-9 14.35 4 0.01 * 0.25
GAD-7 5.84 4 0.21 0.16
* Statistically significant association (p ≤ 0.05); International physical activity questionnaire—IPAQ; Patient Health
Questionnaire-9—PHQ-9; General Anxiety Disorder-7—GAD-7; qui-square result—X2; degrees of freedom—df.
4. Discussion
The main findings of the present study according to the preliminary results were
(i) Swiss participants presented a higher frequency of people without symptoms of de-
pression and anxiety than Brazilian participants, (ii) Brazil was strongly associated with
depression symptoms (effect size = 0.48) and anxiety symptoms (effect size = 0.43), (iii) cur-
rently physical activity level and the change in physical activity level were not different
between the populations of the two countries, (iv) the restriction level was higher in Brazil
compared to Switzerland, and (vi) the restriction level was moderately associated with
depression symptoms (effect size = 0.25) and not associated with anxiety symptoms.
The total number of people living with depression in the world was ~322,000,000
(~4.4% of the global population) and with anxiety was ~264,000,000 (~3.6% of the global
population) in 2015. This number has been steadily increasing around the world in re-
cent years [29,30]. According to the data published by the WHO (2017), prior to the
COVID-19 pandemic, the prevalence of depression and anxiety in Brazil was 5.8% and 9.3%,
respectively, and in Switzerland the prevalence of depression was 5.0% and anxiety 4.9%.
The COVID-19 pandemic brought not only the risk of becoming seriously ill but
also unbearable psychological pressure to the world’s population [31,32]. In this vein,
the need to maintain social isolation to avoid the virus spread exacerbates the vulnerability
of the population to psychological conditions. The present preliminary results showed
that 22.8% of the Brazilian participants investigated by the current study presented a
moderate or severe depression and 17.5% presented a moderate or severe anxiety. This
frequency was significantly lower in the Swiss participants investigated in the current
study, where 7% presented depression and 3.5% presented anxiety. The discrepancy
between the two countries was even higher considering those who had no symptoms
of depression (31.6% Brazilians and 78.9% Swiss) or anxiety (35.1% Brazilian and 77.2%
Swiss). A higher prevalence of these mental diseases was expected to occur in low- and
middle-income countries like Brazil [29]. Of all the present study participants, 100% of the
Swiss and only 38.5% of the Brazilians received more than 2000 dollars per months. In 2017,
the difference in the economic situation between the two countries was similar and the
difference in mental health was much smaller (5.8% and 9.3% of the Brazilians presented
depression and anxiety, respectively, and 5.0% and 4.9% of the Swiss presented depression
and anxiety, respectively (WHO, 2017). Therefore, the current large difference in mental
health symptoms cannot be attributed simply to the economic status of the two countries,
despite the importance of this variable.
According to the restriction level, there were significant differences between the two
countries. In the Swiss sample, there was a much higher frequency (47.4%) of people
who were living without adhering to social distancing than in the Brazilian sample (1.8%).
Therefore, this difference could explain in some manner the anxiety and depression symp-
toms between the two countries, which requires a more careful analysis of this possible
bias. The frequency of anxiety symptoms was significantly higher in the Brazilian than in
the Swiss sample. This higher frequency of anxiety symptoms could be associated with the
greater level of restriction that the Brazilians were experiencing. However, as there are no
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significant association between the level of restriction and the symptoms of anxiety, we can
conclude that the different levels of restriction did not influence the anxiety symptoms.
The same analysis was also performed with respect to the symptoms of depression. The re-
sults showed that there was a significant association between the level of restriction and
the frequency of depression symptoms and Cramer’s V value was 0.22. However, when
the level of association between the countries’ samples and the frequency of depression
was studied, the Cramer’s V value was 0.48. Thus, it can be observed that there was a
greater level of association of depression with the country sample than with the level of
restriction. Therefore, despite the higher level of restriction of Brazilians was influencing
the higher frequency of depression symptoms in this population, it cannot totally explain
the association between country and depression symptoms.
Differences according to the age or sex of the volunteers, knowing factors that could
influence the mental health [12,13,33], are not difference between Brazilian and Swiss
sample, therefore these factors are not influencing the countries mental health differences.
It is known that regular physical activity can minimize the risk of developing depres-
sion [34]; therefore, differences in this level or differences according to the changes in the
physical activity level could influence the prevalence of mental illnesses. However, the pre-
liminary present results showed no difference between Brazilians and Swiss residents
according to their physical activity level or according to the change in physical activity
level adopted during the pandemic period. However, it is possible that the small sample
size was not sufficient to evidence a significant difference between the groups.
Besides the points discussed above that may be associated with mental disorders,
there are many other stressors related to the symptoms of anxiety and depression, such as
dissatisfaction with health information, high risk of contracting COVID-19, lower hospital
beds available, low economic status, and high unemployment rate, that are also considered
risk factors for mental health [12–14]. In Brazil, there is a great divergence of information
about the severity of the COVID-19 pandemic provided by the Health Ministry and the
Republic President, which can leave the population confused about the quality of the
information received [35]. In addition, divergent information can also decrease preventive
care by the population (mask use, hygiene care, social distancing, etc.), increasing the
contamination risk. In fact, the confirmed number of COVID-19 cases is 22,196 per million
in Brazil and 6193 per million in Switzerland by September, 2020 [2]. This situation is
even more serious in Brazil since the number of hospital beds (per 1000 inhabitants)
is 1.95 in Brazil and 3.57 in Switzerland. Corroborating this scenario, the number of
COVID-19 deaths is also much higher in Brazil compared to Switzerland, which presents
676 deaths per million, while Switzerland presents 242 deaths per million [2].
Apart from these potential risk factors for mental health, there are broad differences
in the economic situation of the two countries. The total expenditure on health per capita
is $1318 in Brazil and $6468 in Switzerland. Moreover, the income per capita is $14,750 in
Brazil, and $56,580 [2] in Switzerland. In the same direction, the unemployment rate is
also a bigger problem in Brazil than in Switzerland. Despite both countries presenting an
increase in the unemployment rate, it will rise to 4% in Switzerland (from 2.3% in 2019)
and to 13.3% in Brazil (from 11.9% in 2019). Therefore, the higher number of cases and
deaths by COVID-19, the lower number of hospital beds, the poorer economic conditions,
and the higher unemployment rate may be contributing to the comparatively worse mental
health of Brazilians. However, further studies are needed to clarify why the mental
health of Brazilians was more impacted by the COVID-19 pandemic than that of the
Swiss. Considering that the COVID-19 pandemic has triggered a large economic and social
disruption and political crisis, it is expected that the populations of more vulnerable and
under-developed country like Brazil will suffer more than a stable country like Switzerland.
A limitation of the present study is that it was a cross-sectional study, and the answer
about the level of physical activity adopted before the COVID-19 pandemic was answered
retrospectively. In addition, the questionnaire was applied in both countries in the same
month (first half of June 2020), but the phase in which each country was in relation to the
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COVID-19 pandemic was different, which might have influenced the outcomes achieved.
Moreover, some possible confounding factors, such as: information on marital status,
households (i.e., living alone, with children), race, and ethnicity were not asked to the
volunteers.
Another limitation is the sample size. Although the sample size was sufficient to
identify a significant difference between the two groups for the main variables of the present
study (i.e., anxiety and depression), it may not represent the total population of Brazil
or Switzerland. Therefore, it is important to note that these are preliminary results and
caution should be taken when generalizing the results for the entire countries’ population,
particularly for groups with different characteristics from the samples evaluated in the
present study.
Despite these limitations, these preliminary results showed a large percentage of peo-
ple presenting symptoms of both anxiety and depression highlighting the need of further
investigations with larger sample sizes. The world is not yet free from COVID-19 and
currently many European countries are restricting daily lives again against a new increase
in the number of cases.
5. Conclusions
In conclusion, despite the limitations, the preliminary results showed that the mental
health of Brazilians residents is more compromised than that of Swiss residents, and this
difference is not related to physical activity levels. Although the level of social isolation
adopted by the two countries is impacting the results, it is not the main reason for the
mental health difference between the evaluated countries.
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